Bacil Pharma Ltd
Bacil Pharma Ltd Share Price Today: Live Updates & Key Insights
Get insights on Bacil Pharma Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Bacil Pharma Ltd Share Price Chart
BACILPHARMA at 10 Jul 2026 05:21 PM Pharmaceuticals
38.50 +0.14(+0.37%)
Lowest Today 37.26
Highest Today 39.89
Today's Open 39.50
Prev. Close 38.36
52 Week High 61.80
52 Week Low 26.69
Bacil Pharma Ltd Fundamentals
Traded Volume: 2,29,906
Market Cap(Cr): 55.26
Avg Traded Price 38.69
1 Year return 2.45%
Upper Circuit 39.9
Lower Circuit 37.3
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) 88.51
EPS TTM NaN
Book value/Share NaN
Dividend Yield 1Y 0.00%
Bacil Pharma Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Bacil Pharma Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Bacil Pharma Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y +2.45%
YTD 0.00%
Bacil Pharma Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Bacil Pharma Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Bacil Pharma Ltd Technical Details
Bacil Pharma Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 37
Support 2 37
Support 3 36
Pivot Point : 38
Resistance 1 39
Resistance 2 40
Resistance 3 40
Bacil Pharma Ltd Corporate Actions
Bacil Pharma Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Bacil Pharma Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by BACILPHARMA
Bonus
No Bonus has been declared by BACILPHARMA
Splits
No Split has been declared by BACILPHARMA
Others
Rights No Rights has been declared by BACILPHARMA
Bacil Pharma Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Bacil Pharma Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Bacil Pharma Ltd's relative performance and valuation against major competitors.
Bacil Pharma Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Bacil Pharma Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 1.66 Mar 2025 0.40 Mar 2024 0.00 Mar 2023 -0.15 Mar 2022 -4.01
PARTICULARS Investing Activities Mar 2026 -3.38 Mar 2025 0.34 Mar 2024 0.08 Mar 2023 -0.12 Mar 2022 3.81
PARTICULARS Financing Activities Mar 2026 -0.62 Mar 2025 2.08 Mar 2024 -0.06 Mar 2023 0.06 Mar 2022 0.33
PARTICULARS Net Cash Flow Mar 2026 -2.34 Mar 2025 2.82 Mar 2024 0.01 Mar 2023 -0.20 Mar 2022 0.13
Bacil Pharma Ltd Shareholding Pattern
This shows the ownership breakdown of Bacil Pharma Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Bacil Pharma Ltd
Incorporated as a private limited Company in Maharashtra in May, 1987, Bacil Pharma Limited (BPL) was converted into a Public limited company in October, 1988. The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs. Domestic operations are spread across pan India. The company has strong field force of 500 plus, spread over various States and Districts. It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage. To augment the domestic market, Company's operations are based on focused approach.Multi-Speciality division Vibrant specialises in various specialties, like Anti-Infectives, Pain Management, Respiratory Care, Women's Health, to name a few. Aziwin, Ebay, Balvibe, MNF, Ocium and Monogesic Plus Gel (Innovative Pain Relieving Gel, first time in India) are some of the leading brands in the respective segments. Bal Vedics Division integrates modern medicine with herbal/ayurvedic preparation targeting specific conditions like, Prostrate Enlargement, Renal Calculi, Male Infertility, Women Health etc. Bal Pharma Institutional division is associated with the top Government bodies and Hospitals to extend its product range to the masses. Every area is well covered and supplied through there channel partners.Bal Pharma Unit - 1, is a finished dosage facility for manufacturing Tablets and Capsules. Bal Pharma Unit - 2, is involved in the manufacturing of APIs. A well-equipped R&D laboratory, a good Kilo laboratory and quality control facilities form the other spheres of activity here. Bal Pharma Unit - 3, is a finished dosage facility for manufacturing Intravenous Fluids, Ophthalmic Preparations & Liquid Oral Preparations. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol, norfloxacin, pefloxacin and ciprofloxacin. The company entered into a marketing arrangement with a distributor Kam Han Industries, Hong Kong, to export 50% of the production. Due to various reasons, the civil works at Vapi were affected. However, to avoid further delay in project implementation, the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram (near Ratnagiri).
Executive Director & CFO
Chaitali Kalpataru Shah
Registered office G2 & G3 Samarpan Complex, chakala Andheri East, Mumbai, Maharashtra, 400099
FAX :
Background
Incorporation Year 1987
Face Value ₹10.00
Market Lot 1
FAQs on Bacil Pharma Ltd
How to buy Bacil Pharma Ltd shares?
To buy Bacil Pharma Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Bacil Pharma Ltd?
The company has a market capitalization of ₹55.26.
What is the PE & PB ratio of Bacil Pharma Ltd?
PE is N/A and PB is N/A.
What is the Bacil Pharma Ltd dividend for 2025–26?
For the 2025–26 financial year, Bacil Pharma Ltd declared a final dividend of null% per share.